1-4 of 4
Christopher Sauter, BA
Close
Sort by
Journal Articles

New Interleukin-15 Superagonist (IL-15 SA) Significantly Enhances Graft-Versus-Tumor Activity After Allogeneic Hematopoietic Stem Cell Transplantation

Cavan P Bailey, BA, Christopher Sauter, BA, Michelle M Panis, BS, Tulin Budak-Alpdogan, MD, Hing Wong, PhD, Neal Flomenberg, MD, Onder Alpdogan, MD
Journal: Blood
Blood (2013) 122 (21): 3254.
https://doi.org/10.1182/blood.V122.21.3254.3254
Published: 2013
Journal Articles

Double Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) Enhances Anti-Tumor Activity After Transplant

Tulin Budak-Alpdogan, MD, Cavan P Bailey, BA, Michelle Panis, BS, Christopher Sauter, BA, Vikas Agrawal, MD, Chandra Biswas, MD, Neal Flomenberg, MD, Onder Alpdogan, MD
Journal: Blood
Blood (2012) 120 (21): 1897.
https://doi.org/10.1182/blood.V120.21.1897.1897
Published: 2012
Journal Articles

IL-15 Administration Increases Graft Versus Leukemia Activity in Recipients of Haploidentical Hematopoietic Stem Cell Transplantation,

Christopher Sauter, BA, Chandra Biswas, MD, Cavan Bailey, BA, Michelle Panis, BS, Tulin Budak-Alpdogan, MD, Onder Alpdogan, MD
Journal: Blood
Blood (2011) 118 (21): 4027.
https://doi.org/10.1182/blood.V118.21.4027.4027
Published: 2011
Journal Articles

Double Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) Results In Successful Engraftment of Bone Marrow From Both Donors without Graft Versus Host or Graft Versus Graft Effects.

Chandra Biswas, MD, Daniel Rittenberg, BA, Xiaoling Luo, MS, Christopher Sauter, BA, Dolores Grosso, DNP, Neal Flomenberg, MD, Onder Alpdogan, MD
Journal: Blood
Blood (2010) 116 (21): 1453.
https://doi.org/10.1182/blood.V116.21.1453.1453
Published: 2010